EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Strategies for Improving CAR T Cell Persistence in Solid Tumors

Megen C Wittling iD, Anna C Cole, Brianna Brammer iD, Kailey G Diatikar, Nicole C Schmitt, Chrystal M Paulos

Cancers · 16.08.2024 · 16 (16) · 2858

DOI: 10.3390/cancers16162858 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.08.2024. Verfasst von Megen C Wittling und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Melanoma Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR T cells require optimization to be effective in patients with solid tumors. There are many barriers affecting their ability to succeed. One barrier is persistence, as to achieve an optimal antitumor response, infused CAR T cells must engraft and persist. This singular variable is impacted by a multitude of factors—the CAR T cell design, lymphodepletion regimen used, expansion method to generate the T cell product, and more. Additionally, external agents can be utilized to augment CAR T cells, such as the addition of novel cytokines, pharmaceutical drugs that bolster memory formation, or other agents during either the ex vivo expansion process or after CAR T cell infusion to support them in the oppressive tumor microenvironment. This review highlights many strategies being used to optimize T cell persistence as well as future directions for improving the persistence of infused cells.

Schlagwörter

Stichwörter der Autor:innen

CAR T cellsadoptive cellular therapypersistencesolid tumors

Autor:innen und Institutionen

  • Department of Surgery/Oncology, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA.
  • Department of Microbiology and Immunology, Emory University, Atlanta, GA 30322, USA.
  • School of Medicine, Emory University, Atlanta, GA 30322, USA.
  • Department of Otolaryngology, Emory University, Atlanta, GA 30322, USA.

ORCID-Profile: Megen C Wittling, Brianna Brammer

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Melanoma Research Foundation
  • ARCs Foundation
  • V Foundation

Zitieren

APA

Wittling, M. C., Cole, A. C., Brammer, B., Diatikar, K. G., Schmitt, N. C., & Paulos, C. M. (2024). Strategies for Improving CAR T Cell Persistence in Solid Tumors. Cancers, 16(16), 2858. https://doi.org/10.3390/cancers16162858

Vancouver

Wittling MC, Cole AC, Brammer B, Diatikar KG, Schmitt NC, Paulos CM. Strategies for Improving CAR T Cell Persistence in Solid Tumors. Cancers. 2024;16(16):2858. doi:10.3390/cancers16162858

BibTeX
@article{Wittling2024,
  author = {Wittling, Megen C and Cole, Anna C and Brammer, Brianna and Diatikar, Kailey G and Schmitt, Nicole C and Paulos, Chrystal M},
  title = {Strategies for Improving CAR T Cell Persistence in Solid Tumors},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {16},
  pages = {2858},
  doi = {10.3390/cancers16162858}
}
Kostenlos starten →